BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4147280)

  • 1. Treatment of psycho-neurotic conversion reactions with pindolol. (Effect on cardio-vascular response to exercise).
    Kelesidis G; Hagis P; Samaras C
    Indian Heart J; 1972 Jun; 24():Suppl 1:238-43. PubMed ID: 4147280
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of Fendilin on the exercise test in patients with coronary disease].
    Spiel R; Enenkel W
    Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680
    [No Abstract]   [Full Text] [Related]  

  • 3. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of LB 46 on the blood pressure in essential hypertension.
    Duner H
    Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
    [No Abstract]   [Full Text] [Related]  

  • 6. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of propranolol in essential circulatory hyperkinesis.
    Török E; Matos L; Rausch J; Simonyi J
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):246-52. PubMed ID: 4902019
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of LBI45, practolol and a placebo on the exercise tests of coronary patients. A double-blind study (author's transl)].
    Bloch A; Horvat L
    Schweiz Rundsch Med Prax; 1974 Jan; 63(3):62-5. PubMed ID: 4605646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Exertion insufficiency during beta blocker therapy in the hyperkinetic heart syndrome].
    Niehues B; Hermanns L; Kortenbruck R; Behrenbeck DW; Hilger HH
    Verh Dtsch Ges Inn Med; 1978; (84):736-9. PubMed ID: 742112
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of vegetative cardio-circulatory disorders using beta receptor blockaders. Double blind study on Pindolol-Visken].
    Engel HJ
    Med Welt; 1972 Jul; 23(27):980-4. PubMed ID: 4559279
    [No Abstract]   [Full Text] [Related]  

  • 11. A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
    Srivastava BN; Jain PC; Vyas GP
    Indian Heart J; 1972 Jun; 24():Suppl 1:203-4. PubMed ID: 4581428
    [No Abstract]   [Full Text] [Related]  

  • 12. Usefulness of pindolol for treatment of neurocardiogenic syncope.
    Nair N; Padder FA; Kutalek SP; Kantharia BK
    Am J Cardiol; 2004 Nov; 94(9):1189-91. PubMed ID: 15518620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further indications for Visken.
    Holmes D; Schutz W
    Indian Heart J; 1972 Jun; 24():Suppl 1:244-8. PubMed ID: 4667018
    [No Abstract]   [Full Text] [Related]  

  • 14. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of adrenergic-blocking drugs.
    Louis WJ; Rand MJ; McNeil JJ; Drummer O; Jarrott B
    Cardiology; 1979; 64 Suppl 1():96-104. PubMed ID: 42490
    [No Abstract]   [Full Text] [Related]  

  • 16. Mepindolol sulfate in the hyperkinetic heart syndrome.
    Bonelli J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):42-4. PubMed ID: 6698659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical and hemodynamic effects of propranolol, pindolol and verapamil in the treatment of exertional angina pectoris.
    Johnston DL; Manyari DE; Kostuk WJ
    Can Med Assoc J; 1984 Jun; 130(11):1449-55. PubMed ID: 6145515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The efficiency of coronary therapy with Visken (pindolol). A combined clinical and experimental analysis (author's transl)].
    Delius L; Lübke KO
    Med Klin; 1974 Jun; 69(25):1117-23. PubMed ID: 4602393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta receptor blockaders and nitrites in the treatment of angina pectoris].
    Haarmann K; Neff K
    Schweiz Rundsch Med Prax; 1974 Mar; 63(12):355-9. PubMed ID: 4150716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.